This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
INFANRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA — Description, Dosage, Side Effects | PillsCard
OTC
INFANRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
INN: INFANRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇪🇸🇹🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Glaxosmithkline S.A. (ES)
Source
CIMA_ES
(
ARTG
)
Infanrix is indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole-cell) vaccine. INDICATIONS AS OF 8TH JANUARY 1997 - Infanrix (DTPa) is indicated for active primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. Infanrix (DTPa) is also indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria,tetanus and pertussis (whole-cell or acellular) vaccine.